Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Phytother Res ; 32(10): 1885-1907, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30009484

RESUMO

Natural dietary agents have attracted considerable attention due to their role in promoting health and reducing the risk of diseases including cancer. Ginger, one of the most ancient known spices, contains bioactive compounds with several health benefits. [6]-Gingerol constitutes the most pharmacologically active among such compounds. The aim of the present work was to review the literature pertaining to the use of ginger extract and [6]-gingerol against tumorigenic and oxidative and inflammatory processes associated with cancer, along with the underlying mechanisms of action involved in signaling pathways. This will shed some light on the protective or therapeutic role of ginger derivatives in oxidative and inflammatory regulations during metabolic disturbance and on the antiproliferative and anticancer properties. Data collected from experimental (in vitro or in vivo) and clinical studies discussed in this review indicate that ginger extract and [6]-gingerol exert their action through important mediators and pathways of cell signaling, including Bax/Bcl2, p38/MAPK, Nrf2, p65/NF-κB, TNF-α, ERK1/2, SAPK/JNK, ROS/NF-κB/COX-2, caspases-3, -9, and p53. This suggests that ginger derivatives, in the form of an extract or isolated compounds, exhibit relevant antiproliferative, antitumor, invasive, and anti-inflammatory activities.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Catecóis/farmacologia , Álcoois Graxos/farmacologia , Neoplasias/tratamento farmacológico , Extratos Vegetais/farmacologia , Zingiber officinale/química , Animais , Anti-Inflamatórios/farmacologia , Linhagem Celular Tumoral , Humanos , Inflamação/tratamento farmacológico , Transdução de Sinais/efeitos dos fármacos
3.
Chemosphere ; 204: 220-226, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-29656158

RESUMO

Omeprazole (OME) is a proton pump inhibitor used for the treatment of various gastric and intestinal disease; however, studies on its effects on the genetic materials are still restricted. The present study aimed to evaluate possible toxicogenic effects of OME in Allium cepa meristems with the application of cytogenetic biomarkers for DNA damage, mutagenic, toxic and cytotoxic effects. Additionally, retinol palmitate (RP) and ascorbic acid (AA) were also co-treated with OME to evaluate possible modulatory effects of OME-induced cytogenetic damages. OME was tested at 10, 20 and 40 µg/mL, while RP and AA at 55 µg/mL and 352.2 µg/mL, respectively. Copper sulphate (0.6 µg/mL) and dechlorinated water were used as positive control and negative control, respectively. The results suggest that OME induced genotoxicity and mutagenicity in A. cepa at all tested concentrations. It was noted that cotreatment of OME with the antioxidant vitamins RP and/or AA significantly (p < 0.05) inhibited and/or modulated all toxicogenic damages induced by OME. These observations demonstrate their antigenotoxic, antimutagenic, antitoxic and anticitotoxic effects in A. cepa. This study indicates that application of antioxidants may be useful tools to overcome OME-induced toxic effects.


Assuntos
Allium/efeitos dos fármacos , Ácido Ascórbico/farmacologia , Omeprazol/toxicidade , Toxicogenética/métodos , Vitamina A/análogos & derivados , Antioxidantes/farmacologia , Dano ao DNA/efeitos dos fármacos , Diterpenos , Mutagênese/efeitos dos fármacos , Mutagênicos , Extratos Vegetais/farmacologia , Ésteres de Retinil , Vitamina A/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA